Home/Publication/Bain, IvyCap & Accel Separately Trim Down Interest in Their Listed Portfolios
Bain, IvyCap & Accel Separately Trim Down Interest in Their Listed Portfolios 

11 Jun 2026

US$ 20.00

Bain Capital Private Equity (Bain) has sold virtually all of its remaining stake in India-listed Emcure Pharmaceuticals...

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 12 June 2026...

Peak XV Partners, through its seed investment platform, Surge, has led the US$5 m funding round in Hoola Health. The...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.